CARI Guidelines: Management of cholesterol-lowering therapy in people with chronic kidney disease

Published by David Tunnicliffe on Nov 25, 2021

Disclaimer

Sponsors

Contact

Abstract

Language

en

PICOS

PICO 3.1

Population
People with chronic kidney disease (eGFR ≥15 mL/min/1.73m^2)
Intervention
Statin therapy
Comparator
Placebo or standard of care
Outcomes

PICO 3.2

Population
People with chronic kidney disease (eGFR 15 - 90 mL/min/1.73m^2)
Intervention
Statin therapy plus ezetimibe
Comparator
Statin therapy
Outcomes